| Ambertech Limited (AMO) ORDINARY FULLY PAID |
Information Technology |
$10 |
Results Webinar
|
25 Feb 2026 1:25PM |
$0.150 |
$0.105 |
fallen by
30%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Half Year Report and Appendix 4D
|
25 Feb 2026 1:24PM |
$0.014 |
$0.010 |
fallen by
28.57%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss of $2,898,554 reported for the half-year ending 31 December 2025.
- Revenue decreased by 3.2% to $997,178.
- Significant progress in commercial execution and strategic partnerships.
- Deployment of PROTEQT™ mouthguards at the Winter Olympics.
- Entry into the North American market and retail distribution with Rebel Sport.
- No dividends paid, recommended, or declared during this period.
- Need for additional capital to meet commitments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gentrack Group Limited (GTK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$392 |
Annual Shareholder Meeting Results
|
25 Feb 2026 1:22PM |
$6.480 |
$3.490 |
fallen by
46.14%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$9 |
Change of Director's Interest Notice
|
25 Feb 2026 1:20PM |
$0.200 |
$0.125 |
fallen by
37.50%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$9 |
Change in substantial holding
|
25 Feb 2026 1:16PM |
$0.200 |
$0.125 |
fallen by
37.50%
|
|
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$45 |
New NED Appointments & Extension of Chairman's Employment
|
25 Feb 2026 1:15PM |
$1.090 |
$0.715 |
fallen by
34.40%
|
|
| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$24 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:15PM |
$0.059 |
$0.059 |
fallen by
0%
|
|
CCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the period was $1,705,035.
- Sales revenue for the half-year increased by 45.4% to $237,708.
- Carnegie's principal activities included the development of CETO technology and MoorPower.
- Product development supported by the ACHIEVE Programme and international collaborations.
- Shares issued to improve capital and cash position.
- Garden Island Microgrid contributed significantly to revenue.
- Engagement in several funded project contracts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Vintage Ltd (AVG) ORDINARY FULLY PAID |
Consumer Staple |
$19 |
Change of Director's Interest Notice - James Williamson
|
25 Feb 2026 1:13PM |
$0.086 |
$0.058 |
fallen by
32.56%
|
|
| Australian Finance Group Ltd (AFG) ORDINARY FULLY PAID |
Financials |
$433 |
Ceasing to be a substantial holder from CBA
|
25 Feb 2026 1:09PM |
$1.835 |
$1.595 |
fallen by
13.08%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$266,750 |
Ceasing to be a substantial holder for AFG
|
25 Feb 2026 1:09PM |
$179.765 |
$159.400 |
fallen by
11.33%
|
|
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$85 |
Dividend/Distribution - ACQ
|
25 Feb 2026 1:07PM |
$0.980 |
$0.945 |
fallen by
3.57%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
- |
Court approves Scheme Meeting & Scheme Booklet distribution
|
25 Feb 2026 1:07PM |
$4.675 |
$4.790 |
risen by
2.46%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Federal Court of Australia approved the Scheme Meeting and distribution of Scheme Booklet.
- Proposed acquisition by Daintree BidCo Pty Ltd via scheme of arrangement.
- Scheme Meeting scheduled for 13 April 2026.
- Scheme Booklet to be dispatched by 4 March 2026.
- Independent Expert’s Report concludes the Scheme is fair and reasonable.
- Insignia Financial Board recommends shareholders vote in favor of the Scheme.
- Scheme Consideration of $4.80 per share is within the assessed value range.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$85 |
Half Year Accounts - Appendix 4D
|
25 Feb 2026 1:06PM |
$0.980 |
$0.945 |
fallen by
3.57%
|
|
ACQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $22.921 million, up 306% from the previous year.
- Profit before tax rose to $22.042 million, a 366% increase.
- Profit after tax attributable to members was $15.419 million, a 359% increase.
- Declared interim dividend of 3.50 cents per share, fully franked at 30%.
- Dividend reinvestment plan (DRP) will apply to this and future dividends.
- Net tangible asset backing per share post-tax was $1.2533.
- Financial report reviewed by Ernst & Young for compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4D & Half Year Report 31 December 2025
|
25 Feb 2026 1:04PM |
$0.010 |
$0.009 |
fallen by
10%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 66% to $177,564.
- Net loss after tax decreased by 56% to $514,975.
- The Anti-Obesity Project's compound AOC showed significant activity in pre-clinical studies.
- Delays in Mechanism of Action studies due to international unavailability of a testing kit.
- Successful GaRP-IBS Phase II trial completion.
- Completed a capital raising of A$1.2 million.
- Focused on unmet medical needs in gastrointestinal health.
- Cash at the end of the half year was $1.085 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$157 |
Stealth 1H FY26 Briefing Presentation
|
25 Feb 2026 1:02PM |
$1.280 |
$1.050 |
fallen by
17.97%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record sales of $82.2 million, an 11.8% increase.
- Acquisition of Hardware & Building Traders (HBT) strengthens market position.
- Increased EBITDA of $5.4 million and net profit after tax of $1.6 million.
- Cash balance increased by 212.5% to $32.5 million.
- Focus on leveraging national distribution platform and procurement scale.
- Strong balance sheet with low net debt for future investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPM Minerals Limited (BPM) ORDINARY FULLY PAID |
Materials |
$29 |
Notice of General Meeting/Proxy Form
|
25 Feb 2026 1:01PM |
$0.335 |
$0.220 |
fallen by
34.33%
|
|
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$157 |
Stealth delivers record half year result
|
25 Feb 2026 1:01PM |
$1.280 |
$1.050 |
fallen by
17.97%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Record half-year financial performance with $82.2 million in gross sales.
- Revenue increased to $72.0 million, with EBITDA rising by 18.8%.
- NPAT increased by 51.4%, reaching $1.6 million.
- Acquisition of Hardware & Building Traders (HBT) added 1,165 independent stores.
- Stealth aims for $500 million+ sales by FY28 with a capital-light model.
- Focus on procurement leverage, exclusive brands, and operational efficiency.
- Strengthened balance sheet with a $19.5 million capital raise.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stealth Group Holdings Ltd (SGI) ORDINARY FULLY PAID |
Industrials |
$157 |
Half Yearly Report and Accounts
|
25 Feb 2026 1:00PM |
$1.280 |
$1.050 |
fallen by
17.97%
|
|
SGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Stealth Group Holdings Ltd reported record half-year sales of $82.2 million, an increase of 11.8% from the previous year.
- The company achieved revenue of $72.0 million, up 0.7% from the prior period, and maintained its gross profit margin.
- The underlying EBITDA increased by 17.5% to $5.4 million.
- Net Profit After Tax (NPAT) rose by 1.56% to $1.6 million.
- Operating cash inflow was $1.6 million, with net assets amounting to $49.5 million as of 31 December 2025.
- Stealth Group Holdings completed a $19.5 million capital raising and acquired Hardware & Building Traders Pty Limited.
- The company increased its net assets by $19.3 million from 30 June 2025.
- Intangible assets grew significantly due to acquisitions, with goodwill from acquisitions reaching $42.96 million.
- The balance sheet and cash flows are reported to have strengthened, supporting future growth and transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Imugene Receives $2.7M R&D Tax Refund
|
25 Feb 2026 12:52PM |
$0.250 |
$0.095 |
fallen by
62%
|
|
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$2 |
Update - Proposed issue of securities - ABE
|
25 Feb 2026 12:41PM |
$0.031 |
$0.014 |
fallen by
54.84%
|
|
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$44 |
Anax Metals Limited Investor Webinar
|
25 Feb 2026 12:41PM |
$0.034 |
$0.033 |
fallen by
2.94%
|
|
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$544 |
Appendix 4D and Half Year Report 31 December 2025
|
25 Feb 2026 12:41PM |
$2.010 |
$1.945 |
fallen by
3.23%
|
|
| Claremont Global Fund (Hedged) (Managed Fund) (CGHE) CLAREMONT GLOBAL FUND (HEDGED) ACTIVE ETF |
Financials |
$47 |
Quarterly Portfolio Disclosure - December 2025
|
25 Feb 2026 12:37PM |
$1.615 |
$1.520 |
fallen by
5.88%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$40 |
Half Yearly Report and Accounts
|
25 Feb 2026 12:37PM |
$0.250 |
$0.095 |
fallen by
62%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited reported a loss of $37,820,158 for the half-year ended 31 December 2025.
- The reduction in loss compared to the previous year was mainly due to decreased personnel-related expenses and clinical trial costs.
- Cash reserves as of 31 December 2025 were $14,136,296.
- Azer-cel Phase 1b trial achieved 82% overall response rate in relapsed/refractory DLBCL patients.
- A new collaboration with JW Therapeutics was established to advance the onCARlytics program.
- Operating costs are expected to be approximately 50% lower than the prior financial year.
- The company completed a $22.5 million institutional placement and a $2.42 million Share Purchase Plan.
- Convertible notes were amended for improved cash flow management.
- The company focuses on advancing the azer-cel program, while onCARlytics is expected to benefit from reduced capital expenditure through collaboration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$801 |
Daily Net Tangible Asset Statement
|
25 Feb 2026 12:35PM |
$1.085 |
$1.095 |
risen by
0.92%
|
|
Call 1300 880 160
Start a chat
Schedule a call
